1. Home
  2. PACB vs SOR Comparison

PACB vs SOR Comparison

Compare PACB & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • SOR
  • Stock Information
  • Founded
  • PACB 2000
  • SOR 1968
  • Country
  • PACB United States
  • SOR United States
  • Employees
  • PACB N/A
  • SOR N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • SOR Investment Managers
  • Sector
  • PACB Industrials
  • SOR Finance
  • Exchange
  • PACB Nasdaq
  • SOR Nasdaq
  • Market Cap
  • PACB 364.2M
  • SOR 348.7M
  • IPO Year
  • PACB 2010
  • SOR N/A
  • Fundamental
  • Price
  • PACB $1.33
  • SOR $42.35
  • Analyst Decision
  • PACB Buy
  • SOR
  • Analyst Count
  • PACB 13
  • SOR 0
  • Target Price
  • PACB $2.79
  • SOR N/A
  • AVG Volume (30 Days)
  • PACB 14.6M
  • SOR 16.2K
  • Earning Date
  • PACB 02-13-2025
  • SOR 01-01-0001
  • Dividend Yield
  • PACB N/A
  • SOR 7.24%
  • EPS Growth
  • PACB N/A
  • SOR N/A
  • EPS
  • PACB N/A
  • SOR 6.50
  • Revenue
  • PACB $154,014,000.00
  • SOR N/A
  • Revenue This Year
  • PACB $9.91
  • SOR N/A
  • Revenue Next Year
  • PACB $28.57
  • SOR N/A
  • P/E Ratio
  • PACB N/A
  • SOR $6.41
  • Revenue Growth
  • PACB N/A
  • SOR N/A
  • 52 Week Low
  • PACB $1.16
  • SOR $36.41
  • 52 Week High
  • PACB $4.57
  • SOR $42.75
  • Technical
  • Relative Strength Index (RSI)
  • PACB 40.23
  • SOR 46.79
  • Support Level
  • PACB $1.46
  • SOR $41.86
  • Resistance Level
  • PACB $1.68
  • SOR $42.80
  • Average True Range (ATR)
  • PACB 0.16
  • SOR 0.59
  • MACD
  • PACB -0.02
  • SOR -0.01
  • Stochastic Oscillator
  • PACB 8.11
  • SOR 35.77

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About SOR Source Capital Inc.

Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.

Share on Social Networks: